# K022093: Chase Cardiovascular Patch Kit

- Pathway: 510(k) (Traditional)
- Applicant: Chase Medical, Inc.
- Decided: Sep 20, 2002 after 85 days
- Product code: DXZ (Patch, Pledget And Intracardiac, Petp, Ptfe, Polypropylene)
- Device class: 2
- Regulation: 21 CFR 870.3470
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
No predicates in its family tree.
1 later device descends from it; 1 cites it directly.
0 of 2 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- None. The FDA summary names no predicate by number.

## Most influential descendants
- K040162: Correstore Patch System (2004), 0 descendants of its own

## Indications for use
The CHASE Cardiovascular Patch Kit is indicated for cardiac and vascular patch grafting.

Source page: https://510kreport.com/device/K022093
Methodology: https://510kreport.com/methodology